Marcus Butler

2 articles listing Marcus Butler in Nature Communications, indexed by Paperzzz from Crossref and OSF.

1. Binimetinib and encorafenib for the treatment of advanced solid tumors with non-V600E BRAF mutations: results from the Phase II BEAVER trial Nature Communications
2. Interleukin-12 anchored drug conjugate (tolododekin alfa) in patients with advanced solid tumors: first-in-human Phase 1 trial Nature Communications